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ABSTRACT 
OBJECTIVES: To evaluate the performance and limitations of the R2* and signal intensity ratio 
(SIR) methods for quantifying liver iron concentration (LIC) at 3T. 
METHODS: One hundred and five patients who underwent a liver biopsy with biochemical LIC 
(LICb) were included prospectively. A 3T MRI scan with a breath-hold multiple-echo gradient-echo 
sequence (mGRE) was undertaken for all patients. LIC calculated by 3T SIR algorithm (LICSIR) and 
by R2* (LICR2*) were correlated to LICb. Sensitivity and specificity were calculated. The comparison 
of methods was analyzed for successive classes. 
RESULTS: LICb was strongly correlated to R2* (r = 0.95 p < 0.001) and LICSIR (r = 0.92 p < 0.001). 
In comparison to LICb, LICR2* and LICSIR detect liver iron overload with a sensitivity/specificity of 
0.96 / 0.93 and 0.92 / 0.95, respectively and a bias ± SD of 7.6±73.4 and 14.8±37.6 µmol/g, 
respectively. LICR2* presented the lowest differences for patients with LICb values under 130 µmol/g. 
Above this value, LICSIR has the lowest differences. 
CONCLUSIONS: At 3T, R2* provides precise LIC quantification for lower overload but the SIR 
method is recommended to overcome R2* limitations in higher overload. Our software, available on 
mrquantif.org, uses jointly both methods and selects the best one. 
Ac
ce
pte
d m
an
us
cri
pt
 3 
 
KEYWORDS 
Iron, Liver, Magnetic resonance imaging, Hemosiderosis, Non-alcoholic fatty liver disease, 
Hemochromatosis. 
KEY POINTS 
 Liver iron can be accurately quantified by MRI at 3T 
 At 3T, R2* provides precise quantification of slight liver iron overload 
 At 3T, SIR method is recommended in case of high iron overload 
 Slight liver iron overload present in metabolic syndrome can be depicted. 
 Treatment can be monitored with great confidence. 
 
ABBREVIATIONS 
SIR: Signal intensity ratio 
LIC: liver iron concentration 
LICb: LIC assessed by biopsy using biochemical analysis 
LICSIR: LIC calculated by SIR method 
LICR2*: LIC calculated by T2* conversion 
mGRE: Multiple-echo gradient-echo sequence 
NASH: Non-alcoholic steatohepatitis 
DIOS: Dysmetabolic iron overload syndrome 
MRI: Magnetic resonance imaging 
BMI: Body mass index 
AUC: Area under the curve 
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MAIN TEXT 
Introduction 
Liver iron content (LIC) is a surrogate marker of whole-body iron load. In overload diseases such as 
primary or secondary hemochromatosis, LIC measurement is mandatory for guiding therapeutic 
decisions. Liver iron overload may also be present in non-alcoholic steatohepatitis (NASH) and 
dysmetabolic iron overload syndrome (DIOS), which are both highly prevalent in the Western 
population (1). The main complications are cirrhosis and hepatocellular carcinoma. Many studies (2,3) 
have suggested a close correlation between iron deposition and carcinogenesis. 
The gold-standard method for detecting and quantifying liver iron overload is histopathological 
analysis of a liver sample collected by biopsy with biochemical analysis of the core fragment. The 
biopsy procedure is both invasive and painful and carries some risk of complications (4). In addition, 
the very small liver sample may not be representative of the whole liver in cases of heterogeneous iron 
distribution (5). 
Non-invasive, quantitative assessment of LIC by 1.5T magnetic resonance imaging (MRI) has been 
extensively validated against histology by calculating the relaxation rates R2 and R2* (6–11) and/or 
the signal intensity ratio (SIR) between the liver and paraspinal muscles (12–14). MRI is thus now 
used in routine clinical practice to diagnose, quantify and monitor iron overload (15). 
In recent years, 3T MRI has become more widespread. In view of the shift in magnetic field strength, 
acquisition parameters need to be adapted and new reference values proposed. 
Better sensitivity and accuracy can be expected at 3T, improving diagnosis of DIOS with low iron 
burden. Conversely, quantification of high overload cases may prove more difficult (16). 
Recently, the SIR method, based on several single-echo GRE sequences, has been validated against 
histology at 3T (17).  
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The purpose of our study was to evaluate the ability of the R2* method to detect and quantify liver 
iron at 3T using biochemical quantification as the reference method. Our secondary goal was to 
compare, at the 3T field strength, two major LIC quantification methods: R2* and SIR. 
Materials and Methods 
Patient population 
Between January 2007 and January 2013, all patients referred for liver biopsy and in whom liver iron 
overload was suspected according to their disease were prospectively recruited. All patients provided 
written informed consent to participate in this prospective single-center clinical trial. In addition to 
usual care, an MRI scan was scheduled to assess hepatic iron stores. Age, sex and body mass index 
were recorded. 
Biochemical liver iron concentration  
Liver biopsy was indicated as per the guidelines of the American Association for the Study of Liver 
Diseases (18,19). A biopsy sample was taken from the right lobe of the liver using a 16 gauge needle 
(Hepafix 16G, Braun, Melsingen, Germany) under ultrasound guidance. Biochemical liver iron 
concentration (LICb) was measured using Barry and Sherlock's method for biopsy samples taken from 
paraffin-embedded blocks (20). Liver iron overload was defined as an LICb greater than 35 µmol/g 
(dry liver). Biochemical analysis was blinded to MRI results. 
Magnetic resonance imaging protocol 
The study was performed with two 3T MRI scanners: first with Achieva (Philips, Best, Netherlands) 
and then with Magnetom Verio (Siemens Healthcare, Erlangen, Germany). The body coil was used as 
the receive coil to achieve homogeneous signal intensity in the imaged section and avoid signal depth 
fall-off. Only the Siemens scanner had a compensation method for better B1 homogeneity. There was 
a slight difference in resonance frequency (127.79 vs. 123.24 MHz) between the two scanners. Using 
the body coil, one multi-echo gradient echo (mGRE) sequence was performed, with 11 echoes. The 
selected TEs were slightly different depending on the scanner: a multiple of 1.15 ms for the Philips 
group and 1.23 ms for the Siemens group. Pixel bandwidth was 1161 Hz for the Philips group and 
A
c
pte
d m
an
us
cri
pt
 6 
1048 Hz for the Siemens group. The remaining parameters were identical for both machines: 
400x400mm2 field of view; 128*121 acquisition matrix; 256x256 reconstruction matrix with a pixel 
size of 1.56x1.56 mm²; 120 ms repetition time; 20° flip angle; 7 mm slice thickness; 1 excitation. The 
breath-hold acquisition lasted 15s.  
MRI data analysis 
Measurements were conducted using an in-house Java program integrating ImageJ functions (NIH, 
Bethesda, USA). All data were analyzed by a radiologist (with 10 years' experience in abdominal 
radiology) who was blind to clinical information and to the biopsy result. 
On the selected slice, 3 ROIs with a diameter of 2.5 cm (4.9 cm²) were placed in the right liver area, 
taking care to avoid large vessels, biliary tracts, parenchymatous lesions and artifacts, 2 ROIs with a 
diameter of 2 cm (3.1 cm²) in the right and left paraspinal muscles and 1 ROI with a diameter of 3 cm 
(7.1 cm²) in the air outside of the body for noise measurement. All ROIs were automatically copied to 
the same place on each echo of this selected location. The placement of the ROIs is illustrated in 
Figure 1. 
Before performing fitting, we applied a noise subtraction algorithm to subtract the mean background 
noise from the liver signal. Then T2* values were automatically calculated using a simplex non-linear 
algorithm to fit the magnitude of the complex signal from all echoes or only from in-phase echoes 
when the signal of the first out-of-phase echo was lower than the signal of the first in-phase echo.  
Thus T2* was calculated according to the formula:  𝐿𝑖𝑣𝑒𝑟 𝑠𝑖𝑔𝑛𝑎𝑙 − 𝑛𝑜𝑖𝑠𝑒 = 𝑀0. 𝑒−(
𝑇𝐸
𝑇2∗
)
 
R2* was calculated as follows: R2* = 1/T2*, and we used the linear correlation with LICb to 
determine LICR2*. 
The liver-to-muscle signal intensity ratio (SIR) method was used to calculate LICSIR with the 
algorithm derived from the same patient series using 5 single-echo GRE sequences (17). Only the first 
four echoes of this formula were used to calculate LICSIR since the longest fifth echo (14 ms) was not 
obtained in the mGRE acquisition. 
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Statistical analysis  
Statistical analyses were performed using SAS 9.4 (SAS Institute, Cary, NC). 
Qualitative variables were expressed as numbers and percentages. Quantitative data were expressed as 
means ± standard deviations (SD) if normally distributed and medians (Q1-Q3) if not normally 
distributed. 
Given that LIC quantification variables were not normally distributed, we calculated non-linear 
correlation coefficients (Spearman) to estimate the strength of the linear relationship between LICR2* 
or LICSIR and LICb.  
Similarly, in order to compare measurements using the Philips or Siemens scanner, Generalized 
Poisson Mixed Models (GLIMMIX procedure) were used with or without adjustment for sex, BMI 
and age. 
Agreement between LIC quantifications was assessed using the Bland and Altman method, calculating 
the mean difference (estimated bias, d), the standard deviation of the differences (precision, SD), and 
the limits of agreement (d±1.96SD). Student's t-test was used to determine whether the bias between 
measurement methods was significant. 
Optimal cut-off values for the threshold of LICb at 36 µmol/g were obtained by optimization of the 
Youden index from AUROC curve analysis.  
The area under the curve, sensitivity, specificity, positive and negative predictive values were 
calculated for both LICR2* and LICSIR. 
In order to compare the two methods at different levels, the cohort was divided into equal successive 
classes according to the values of LICb. Then, LICb - LICR2* and LICb - LICSIR were calculated and 
compared at the different LICb levels. A similar comparison, corresponding more to the practical 
intent to diagnose, was also done by using LICR2* classes. 
P values less than 0.05 were considered statistically significant.  
 
RESULTS 
Patient population 
One hundred and five patients were prospectively included between January 2007 and January 2013 
(Figure 2). Fifty-eight (55%) had hyperferritinemia, 52 (50%) had metabolic syndrome, 15 (14%) had 
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chronic alcohol intoxication, 15 (14%) had either hepatitis B or C, and 6 (6%) had other liver diseases 
(autoimmune hepatitis, primary biliary cirrhosis). 
The first 36 patients (34%) included were scanned with the Philips scanner and the following 69 
(66%) with the Siemens scanner. Mean (±SD) age was 55.8±12.7 and 50±12.8 years for women and 
men, respectively (p=0.03). One hundred and one patients underwent the MRI examination and the 
biopsy on the same day while 4 patients experienced an interval between the biopsy and MRI of less 
than 15 days. The LICb concentration ranged from 0 to 630 µmol/g, and 49 patients (47%) had normal 
LICb values < 36 µmol/g. Fifty six patients had a liver iron overload. It was due to genetic 
hemochromatosis in 31 patients (LICb mean=286±148 µmol/g, range=43-630 µmol/g), to 
dysmetabolic syndrom in 22 patients (LICb mean=62±27 µmol/g, range=36-123 µmol/g) and to other 
causes (alcoholic or viral hepatitis) in 3 patients (LICb mean= 42±5 µmol/g, range=36-46 µmol/g). 
Patient characteristics are provided in Table 1. 
Our analysis without / with the adjustment for BMI, sex and age yielded no difference in the 
distribution of LICb (p=0.65 / p=0.19), LICR2* (p=0.49 / p=0.14) and LICSIR (p=0.50 / 0.27) results 
between the two groups using MRI machines from different manufacturers. 
R2* and LICR2* measurements 
Linear regression between LICb and R2* is shown in Figure 3a and yielded the following equation:  
  LICR2* (µmol/g) = 0.316 R2* +7.6 
The Spearman correlation coefficient (r = 0.95 p < 0.001) indicates a strong positive correlation 
between LICb and R2*. 
Figure 3b shows the Bland-Altman plot of the difference vs. mean values of LICb and LICR2* 
measurements. The bias (SD) or average difference between the results of the two methods was 7.6 
(73.4) µmol/g and the 95% limits of agreement were -136.4 µmol/g and 151.5 µmol/g. The bias was 
not statistically significantly different to zero (p= 0.74).  
With the reference threshold established at LICb = 36 µmol/g, ROC curves obtained with LICR2* results 
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showed an area under the curve (AUC) of 0.987. The best threshold was given for LICR2* at 
32 µmol/g, corresponding to an R2* of 77 s-1, and a T2* of 13 ms, with 47 true positives, 4 false 
positives, 52 true negatives and 2 false negatives. The sensitivity was 0.96 (95% CI: 0.9; 1.01) and the 
specificity 0.93 (95% CI: 0.86; 1.0). 
Taking in consideration only the 76 patients with LICb below 130µmol/g, linear regression yielded the 
following equation:  
  LICR2* (µmol/g) = 0.314 R2* - 0.96  
The best threshold was then given for LICR2* at 27 µmol/g, corresponding to an R2* of 89 s-1, and a 
T2* of 11 ms, with 44 true positives, 2 false positives, 25 true negatives and 5 false negatives. The 
sensitivity was 0.90 (95% CI: 0.81; 0.98) and the specificity 0.93 (95% CI: 0.83; 1.0). 
LICSIR measurement 
Linear regression between LICb and LICSIR is shown in Figure 3c. The Spearman correlation 
coefficient (r = 0.92 p < 0.001) indicates a strong positive correlation between LICSIR and LICb. Figure 
3d shows the Bland-Altman plot of the difference vs. mean values of LICb and LICSIR measurements. 
The bias (SD) or average difference between the results of the two methods was 14.8 (37.6) and the 
95% limits of agreement were -59.0 and 88.5 µmol/g. The bias was statistically significantly different 
to zero (p<0.0001). 
With the reference threshold established at LICb = 36 µmol/g, the ROC curves obtained with LICSIR 
results showed an AUC of 0.965. The best threshold was given for LICSIR = 20 µmol/g with 45 true 
positives, 3 false positives, 53 true negatives and 4 false negatives. The sensitivity was 0.92 (95% CI: 
0.84; 0.99) and the specificity 0.95 (95% CI: 089; 1.0). 
Comparison between LICR2* and LICSIR measurements 
The Spearman correlation coefficient (r = 0.95 p < 0.001) indicates a strong positive correlation 
between LICR2* and LICSIR. Figure 4 shows the mean differences (absolute values) between LICSIR and 
LICb or between LICR2* and LICb according to LICb or LICR2* class. With LICb classes, LICR2* 
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presented the lowest differences for patients with LICb values under 130 µmol/g and the highest 
differences for patients above 190 µmol/g (Figure 4a). Using LICR2* classes, the differences increased 
above 130 µmol/g (Figure 4b).  
 
DISCUSSION  
With a shortest TE of 1.2 ms, liver iron overload can be reliably quantified by MRI at 3T with  the 
R2* for patients with biopsy-proven LIC under 130 µmol/g but the SIR method appears more robust 
for higher iron overload. 
The R2* calculation is well known and its clinical use is well established at 1.5T. In the literature, 
there are 5 main publications, validating R2* against LIC determined by biopsy (6,8–11). Conversion 
formulas have been proposed to estimate LIC from R2* (s-1) with a slope of 0.025 to 0.032 to obtain 
the LIC value in mg/g. Pooling the data from the main publications, Henninger found a mean slope of 
0.029 (11). Then, to obtain the LIC in µmol instead of mg/g, we multiplied this mean slope by 18 to 
obtain 0.52. So, at 1.5T, simply by dividing by 2 the value of R2* expressed in s-1 we have a correct 
approximation of LIC expressed in µmol/g. 
No such validation with biopsies has been done at 3T. Theoretical calculations suggest a doubling of 
R2* from 1.5 to 3T (21). Then the mean slope to obtain the LIC value in µmol/g should be divided by 
2 and should be approximately 0.26. Anwar's (22) results in 5 patients seem to confirm this hypothesis 
but with significant delay between MRI and biopsy. However, in our series we obtained a slope of 
0.316, slightly higher than the slope expected by extrapolation of 1.5T polled data but close to half the 
higher slope proposed at 1.5T by Garbowski, who used the same laboratory reference (10). In our 
series, the background noise subtraction leads to a higher value of R2* and partly explains the residual 
difference with Garbowski's results. This emphasizes the need for a standardized protocol to obtain 
more comparable results. 
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The higher magnetic susceptibility observed at 3T introduced limitations in the R2* calculation. For 
high overloads, there is a strong decrease in liver signal intensity. It is then difficult to obtain a correct 
exponential curve fit. 
The SIR method is also widely recognized and used for hepatic iron quantification at 1.5T. Our study 
evaluated this method at 3T using the algorithm defined from single-echo sequences (17). The results 
we obtained with an mGRE sequence showed good correlations but with a slight overall 
overestimation and a slight underestimation for low values because the longest TE, around 14 ms, was 
not included in the mGRE sequence. For slight to moderate overloads, below 130 µmol/g, almost 
exclusively patients with DIOS, our study showed a better correlation of the R2* method than the SIR 
method to LICb. However, in patients with high LICb above 130 µmol/g, corresponding exclusively, in 
our study, to patient with genetic hemochromatosis, the SIR method provides a better correlation to 
LICb. At 1.5T, quantification was possible by SIR up to 350 µmol/g by using the shortest in-phase TE 
of 4 ms. Rose overcomes this limit by using a shorter first TE of 1.8 ms (23). At 3T, a first TE of 
1.2 ms is short enough to give a liver signal over the signal noise and to allow a SIR estimation in high 
overload.  
Our study is the largest series calibrating R2* versus LICb, for any magnetic field strength. It validates 
the use of 3T MRI for hepatic iron quantification. In comparison to the biopsy with biochemical 
determination of iron, we propose a formula to convert R2* at 3T to LICb. Despite variation in 
technical characteristics, there was no significant difference between the two machines used. Although 
the use of 3T MRI is becoming more widespread, some centers only have a 3T magnetic field for 
abdominal imaging. There is a strong need for reference values at 3T. Moreover, the use of a 3T 
magnetic field allows for more accurate quantification of slight to moderate overloads. Improving 
sensitivity is clinically relevant regarding the increasing incidence of DIOS with low iron overload.  
Our study has certain limitations. First, the shortest TE was about 1.2 ms, a value which is also the 
first TE usually proposed by MR vendors in most built-in protocols dedicated to hepatic iron and fat 
quantification. Obviously, this TE is not short enough at 3T to correctly calculate R2* in the case of 
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high overload. It is technically difficult to use a first TE of 0.4 ms, which is half the shortest TE of 
0.8 ms proposed by Wood at 1.5T (8). Very short TEs will be available using ultrashort echo time 
(UTE) imaging (24). In the meantime, the main risk is not being unable to quantify correctly a high 
overload, which has only a small impact on patient management, but miscalculating R2* and hence 
underestimating liver iron overload. For example a patient with an R2* of 512 s-1, corresponding to an 
LICR* of 130 µmol/g, actually had an LICb of 480 µmol/g. This type of error explains how the 
difference between LICR2* and LICb increases faster with LICR2* classes than with LICb classes. So, to 
overcome this limitation, we propose either greatly reducing the shortest TE or combining both SIR 
and T2* methods. Second, we used two different machines with a slight magnetic field difference 
(3%). Acquisition parameters were as close as possible. However, there were also slight TE 
differences (8%). This could have produced errors particularly for the SIR method which does not take 
into account TE differences between the two units. The absence of B1 heterogeneity correction with 
the first machine may also lead, in some cases, to an overestimation of LICSIR through reduction of the 
paraspinal muscle signal, as described with single-echo sequences (17). Third, we used the body coil 
for both methods. This coil is necessary for the SIR method. A surface coil allows a higher signal for 
R2* calculation but this is offset by larger voxels (17mm3) and T2* fitting to the entire ROI instead of 
producing a pixel-wise map. Fourth, we only use 4 of the 5 echoes used by the 3T SIR algorithm 
based on single-echo sequences. This explains the bias observed for the low values of LICb with a 
LICSIR cut-off of 20 µmol/g for determining overloaded patients. A new version of the algorithm 
taking into account the reduction in the number of echoes obtained has now been incorporated into our 
dedicated software. Nevertheless, this has no practical impact since at that level of overload R2* is the 
most precise method. 
This study validates hepatic iron quantification by MRI at 3T, with a conversion formula to LICb 
obtained from biopsy material. With the selected TEs, the R2* method is more accurate for slight to 
moderate hepatic iron overload whereas the SIR method is more accurate for high overloads. Shorter 
TEs are needed to improve performance for quantifying massive iron overload by R2* [24]. In the 
meantime, both methods should be used simultaneously with a breath-hold mGRE sequence acquired 
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using the body coil. The sequence protocol we propose can be applied to the majority of MRI scanners 
without the need to purchase a specific option. Detailed sequence parameters and a dedicated DICOM 
software program, incorporating both calculations with cross-checks, are available at 
www.mrquantif.org 
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TABLES 
 
Table 1: Patient characteristics (n=105) 
 
Male/Female 68/37 
Mean age (SD) 52.1 (+/-13) 
MRI scanner manufacturer (Siemens/Philips) 69/36 
Body Mass Index, mean (SD) 27.8 (4.2) 
LICb µmol/g, median [interquartile range] 37.5 [18.2 - 130.1] 
LICSIR µmol/g, median [interquartile range] 30 [0 - 120] 
LICR2* µmol/g, median [interquartile range] 32.9 [18.5-117.7] 
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FIGURE CAPTIONS 
Figure 1: Screen-copy of the in-house software viewer with example of ROIs placement. 
Figure 2: Flow chart. 
Figure 3: Comparison between LICb and R2* or LICSIR: a) Linear regression between R2* and LICb, 
b) Bland-Altman plot of the difference vs. average of LICR2*, c) Linear regression between LICSIR and 
LICb, and d) Bland-Altman plot of the difference vs. average of LICSIR in comparison to LICb 
Figure 4: Mean of absolute differences between LICb and LICR2* or LICSIR according to a) (Figure 5a) 
LICb classes or b) (Figure 5b) LICR2* classes 
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